KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

TherapeuticsMD (TXMD) Other Operating Expenses (2016 - 2025)

TherapeuticsMD's Other Operating Expenses history spans 16 years, with the latest figure at $153000.0 for Q4 2025.

  • For Q4 2025, Other Operating Expenses rose 42.99% year-over-year to $153000.0; the TTM value through Dec 2025 reached $560000.0, down 68.49%, while the annual FY2025 figure was $560000.0, 68.49% down from the prior year.
  • Other Operating Expenses reached $153000.0 in Q4 2025 per TXMD's latest filing, up from $128000.0 in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $143.4 million in Q2 2022 to a low of -$93.3 million in Q4 2021.
  • Average Other Operating Expenses over 5 years is $8.2 million, with a median of $143000.0 recorded in 2024.
  • Peak YoY movement for Other Operating Expenses: crashed 458.82% in 2021, then soared 392.59% in 2024.
  • A 5-year view of Other Operating Expenses shows it stood at -$93.3 million in 2021, then soared by 110.27% to $9.6 million in 2022, then crashed by 94.4% to $537000.0 in 2023, then crashed by 80.07% to $107000.0 in 2024, then skyrocketed by 42.99% to $153000.0 in 2025.
  • Per Business Quant, the three most recent readings for TXMD's Other Operating Expenses are $153000.0 (Q4 2025), $128000.0 (Q3 2025), and $96000.0 (Q2 2025).